CRC Industries

Zymergen | September 09, 2020

Science and material innovation company Zymergen today announced $300M in new investment to accelerate its delivery of revolutionary, high performance materials. The investment includes initial Series D funding led by Baillie Gifford, joined by Baron Capital Group and one of the world's largest sovereign wealth funds, as well as additional growth financing from Perceptive Advisors. A number of current investors are also returning, and Zymergen expects to raise additional capital in Q4 as par...

NOVA Chemicals | October 21, 2020

NOVA Chemicals Corp. announced that it has agreed to sell its expandable styrenics business to a subsidiary of Alpek S.A.B. de C.V. (San Pedro Garza Garcia, Mexico). The parties expect to close the transaction in the fourth quarter. The sale of its expandable styrenics business is an important step in NOVA Chemicals’ plan to focus on its olefin and polyethylene business, which includes additional investments to advance a global circular economy for plastic. “This transaction provides...

PR Newswire | January 28, 2020

SOCMA is pleased to announce two new services for the chemical industry – a modernized Chemical Operations Tool and a new Career Center – that will assist companies in addressing workforce development challenges. "SOCMA understands the ongoing challenge in finding qualified workers and ensuring that new and existing workers receive quality training," said Jennifer Abril, SOCMA President and CEO. "We also realize a new generation of workers is coming into the industry a...

Baylor College of Medicine | July 10, 2020

Scientists at Baylor College of Medicine have devised a chemical approach for discovering new enzyme-binding compounds that could be developed into drugs for various illnesses and conditions. This process can be used to support development of novel antiviral drugs for use in the continuing COVID-19 pandemic. The study, published online today in the Proceedings of the National Academy of Sciences USA, was co-led by Dr. Surendra Dawadi, instructor in the Center for Drug Discovery at...